Mylan Launches Generic Viramune Tablets

Mylan announced the launch of Nevirapine tablets 200mg, the generic version of Boehringer Ingelheim's Viramune tablets 200mg.

Viramune is a non-nucleoside reverse transcriptase inhibitor (NNRTI) indicated for combination antiretroviral treatment of HIV-1 infection. NNRTIs non-competitively bind to HIV-1 reverse transcriptase at a site far from the catalytic nucleoside/nucleotide binding site. This action causes a conformational change in the enzyme which dramatically reduces its activity.

Nevirapine tablets are available from Mylan in 12-count packs.

For more information call (800) RX-MYLAN or visit www.mylan.com.